IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,905,120 | +10.6% | 42,000 | 0.0% | 0.29% | +16.1% |
| Q2 2023 | $1,723,260 | +14.8% | 42,000 | 0.0% | 0.25% | +7.3% |
| Q1 2023 | $1,501,080 | -5.4% | 42,000 | 0.0% | 0.23% | -9.7% |
| Q4 2022 | $1,586,340 | -14.6% | 42,000 | 0.0% | 0.26% | -19.2% |
| Q3 2022 | $1,858,000 | +19.5% | 42,000 | 0.0% | 0.32% | +25.7% |
| Q2 2022 | $1,555,000 | 0.0% | 42,000 | 0.0% | 0.25% | +20.5% |
| Q1 2022 | $1,555,000 | +21.7% | 42,000 | 0.0% | 0.21% | +30.4% |
| Q4 2021 | $1,278,000 | -9.2% | 42,000 | 0.0% | 0.16% | -15.7% |
| Q3 2021 | $1,408,000 | -16.0% | 42,000 | 0.0% | 0.19% | -14.3% |
| Q2 2021 | $1,676,000 | -11.3% | 42,000 | 0.0% | 0.22% | -17.1% |
| Q1 2021 | $1,889,000 | +178.6% | 42,000 | +250.0% | 0.27% | +156.2% |
| Q4 2020 | $678,000 | +19.2% | 12,000 | 0.0% | 0.10% | +2.9% |
| Q3 2020 | $569,000 | -19.6% | 12,000 | 0.0% | 0.10% | -23.3% |
| Q2 2020 | $708,000 | +24.9% | 12,000 | 0.0% | 0.13% | +2.3% |
| Q1 2020 | $567,000 | -21.8% | 12,000 | 0.0% | 0.13% | +5.7% |
| Q4 2019 | $725,000 | +0.8% | 12,000 | 0.0% | 0.12% | -6.1% |
| Q3 2019 | $719,000 | -6.7% | 12,000 | 0.0% | 0.13% | -5.1% |
| Q2 2019 | $771,000 | -20.8% | 12,000 | 0.0% | 0.14% | -22.0% |
| Q1 2019 | $974,000 | -40.0% | 12,000 | -60.0% | 0.18% | -47.6% |
| Q4 2018 | $1,622,000 | +4.8% | 30,000 | 0.0% | 0.34% | +28.0% |
| Q3 2018 | $1,547,000 | +12.5% | 30,000 | -9.1% | 0.26% | +7.3% |
| Q2 2018 | $1,375,000 | -8.2% | 33,000 | -2.9% | 0.25% | -7.9% |
| Q1 2018 | $1,498,000 | -19.5% | 34,000 | -8.1% | 0.27% | -17.1% |
| Q4 2017 | $1,861,000 | -18.4% | 37,000 | -17.8% | 0.32% | -22.2% |
| Q3 2017 | $2,282,000 | -10.3% | 45,000 | -10.0% | 0.41% | -13.8% |
| Q2 2017 | $2,543,000 | -9.6% | 50,000 | -28.6% | 0.48% | -10.3% |
| Q1 2017 | $2,814,000 | -15.9% | 70,000 | 0.0% | 0.54% | -19.5% |
| Q4 2016 | $3,348,000 | +30.5% | 70,000 | 0.0% | 0.66% | +25.2% |
| Q3 2016 | $2,565,000 | +57.3% | 70,000 | 0.0% | 0.53% | +53.0% |
| Q2 2016 | $1,631,000 | -49.9% | 70,000 | 0.0% | 0.35% | -49.9% |
| Q1 2016 | $3,257,000 | -24.9% | 70,000 | 0.0% | 0.69% | -22.0% |
| Q4 2015 | $4,335,000 | – | 70,000 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |